PL2854794T3 - Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy - Google Patents

Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy

Info

Publication number
PL2854794T3
PL2854794T3 PL13725972T PL13725972T PL2854794T3 PL 2854794 T3 PL2854794 T3 PL 2854794T3 PL 13725972 T PL13725972 T PL 13725972T PL 13725972 T PL13725972 T PL 13725972T PL 2854794 T3 PL2854794 T3 PL 2854794T3
Authority
PL
Poland
Prior art keywords
granules containing
glyceryl trinitrate
containing glyceryl
stabilized granules
inducing arteriogenesis
Prior art date
Application number
PL13725972T
Other languages
English (en)
Inventor
Michaela Gorath
Original Assignee
G Pohl Boskamp Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G Pohl Boskamp Gmbh & Co Kg filed Critical G Pohl Boskamp Gmbh & Co Kg
Publication of PL2854794T3 publication Critical patent/PL2854794T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL13725972T 2012-05-31 2013-05-29 Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy PL2854794T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261653601P 2012-05-31 2012-05-31
EP12004188.4A EP2668948A1 (en) 2012-05-31 2012-05-31 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
PCT/EP2013/061128 WO2013178713A1 (en) 2012-05-31 2013-05-29 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis
EP13725972.7A EP2854794B1 (en) 2012-05-31 2013-05-29 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis

Publications (1)

Publication Number Publication Date
PL2854794T3 true PL2854794T3 (pl) 2019-04-30

Family

ID=46275672

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13725972T PL2854794T3 (pl) 2012-05-31 2013-05-29 Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy

Country Status (5)

Country Link
EP (3) EP2668948A1 (pl)
ES (1) ES2704649T3 (pl)
PL (1) PL2854794T3 (pl)
TR (1) TR201820481T4 (pl)
WO (1) WO2013178713A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2668947B1 (en) * 2012-05-31 2016-11-30 G. Pohl-Boskamp GmbH & Co. KG Induction of arteriogenesis with a nitric oxide-donor such as nitroglycerin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1019039B1 (en) * 1997-10-03 2001-12-05 Warner-Lambert Company Compressed nitroglycerin tablet and its method of manufacture
DE102008005484A1 (de) * 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
EP2378957B1 (en) 2008-12-23 2015-09-30 Charité - Universitätsmedizin Berlin Method and device for monitoring arteriogenesis

Also Published As

Publication number Publication date
EP3482757A1 (en) 2019-05-15
EP2854794A1 (en) 2015-04-08
EP2668948A1 (en) 2013-12-04
ES2704649T3 (es) 2019-03-19
EP2854794B1 (en) 2018-10-10
TR201820481T4 (tr) 2019-01-21
WO2013178713A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
GB2509040B (en) Stabilization of resistive memory
IL233482B (en) Stabilized formulations that include anti-ang2 antibodies
IL232789A0 (en) Stable formulations with controlled release
PL2877155T3 (pl) Formulacje opioidowe
IL236304A0 (en) Formulations for diclofenac
IL289157A (en) Opioid compounds
SG11201405578TA (en) Pharmaceutical composition containing peptide
IL239395A0 (en) Diclofenac preparation
SG11201501122WA (en) Solid pharmaceutical preparation containing levothyroxine
ZA201504003B (en) Stabilizing system
SG11201500119QA (en) Deluge system
EP2729164A4 (en) FORMULATIONS STABILIZING PROTEINS
GB2519682B (en) Granulation system
EP2813796A4 (en) SPECIAL CARTRIDGE (AND VARIANTS)
EP2852607A4 (en) IMPROVED SYNTHESIS
PL2678000T3 (pl) Stabilizowane granulaty zawierające triazotan glicerolu
PL2854794T3 (pl) Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy
ZA201405168B (en) Support for facets
GB2501945B (en) Deluge system
GB2510757B (en) Deluge system
ZA201404909B (en) Stabilized formulations containing anti-ang2 antibodies
GB201215324D0 (en) Improved deluge system
HU1000302D0 (en) Dedicated dissolvent
GB201212600D0 (en) Bongo
GB201204587D0 (en) Prodrugs of guanidine compounds